Market revenue in 2023 | USD 138.3 million |
Market revenue in 2030 | USD 276.4 million |
Growth rate | 10.4% (CAGR from 2023 to 2030) |
Largest segment | Single-phase product |
Fastest growing segment | Single-Phase Product |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single-Phase Product, Duplex Products |
Key market players worldwide | Allergan, Merz Pharma, Anika Therapeutics Inc, LG Chem, Sinclair Pharma plc, Laboratoires Vivacy, Genzyme, Bio-Plus, Bioxis Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hyaluronic acid based dermal fillers market will help companies and investors design strategic landscapes.
Single-phase product was the largest segment with a revenue share of 54.45% in 2023. Horizon Databook has segmented the South Korea hyaluronic acid based dermal fillers market based on single-phase product, duplex products covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea’s hyaluronic acid-based dermal fillers market is driven by the growing number of players entering into strategic partnerships & novel product launches. HA dermal filler range will be sold under the brand AiLEENE and constitute three products with different viscosity & elasticity.
According to the Ethos Spa article, the market emphasizes the significance of proper regulation to ensure the safety & efficacy of dermal fillers. Potential users are advised to verify the regulatory status of the brands they choose for hyaluronic acid dermal filler treatments.
Furthermore, specific elimination criteria are summarized, highlighting that individuals with prior allergic reactions, bleeding disorders, skin infections, cold sores, and those who are pregnant or breastfeeding should avoid Korean dermal fillers. This responsible approach aligns with industry standards, advancing consumer trust.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea hyaluronic acid based dermal fillers market , including forecasts for subscribers. This country databook contains high-level insights into South Korea hyaluronic acid based dermal fillers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account